Gerosa, M.; Schioppo, T.; Argolini, L.M.; Sciascia, S.; Ramirez, G.A.; Moroni, G.; Sinico, R.A.; Bonelli, G.; Alberici, F.; Mescia, F.;
et al. The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. Vaccines 2022, 10, 663.
https://doi.org/10.3390/vaccines10050663
AMA Style
Gerosa M, Schioppo T, Argolini LM, Sciascia S, Ramirez GA, Moroni G, Sinico RA, Bonelli G, Alberici F, Mescia F,
et al. The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. Vaccines. 2022; 10(5):663.
https://doi.org/10.3390/vaccines10050663
Chicago/Turabian Style
Gerosa, Maria, Tommaso Schioppo, Lorenza Maria Argolini, Savino Sciascia, Giuseppe Alvise Ramirez, Gabriella Moroni, Renato Alberto Sinico, Grazia Bonelli, Federico Alberici, Federica Mescia,
and et al. 2022. "The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study" Vaccines 10, no. 5: 663.
https://doi.org/10.3390/vaccines10050663
APA Style
Gerosa, M., Schioppo, T., Argolini, L. M., Sciascia, S., Ramirez, G. A., Moroni, G., Sinico, R. A., Bonelli, G., Alberici, F., Mescia, F., Moroni, L., Tamborini, F., Miraglia, P., Bellocchi, C., Beretta, L., Roccatello, D., Dagna, L., Bozzolo, E., & Caporali, R.
(2022). The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study. Vaccines, 10(5), 663.
https://doi.org/10.3390/vaccines10050663
